Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

NDA for Plenaxis denied FDA approval

June 14, 2001

Takeda compounds inhibit testosterone synthesis, useful for sex steroid-dependent disorders

June 13, 2001

Preparation and methods of use of new uPAR antagonists

June 13, 2001

Novel taxanes with improved profile designed at Daiichi

June 13, 2001

First launch for Myocet, a new breast cancer therapy

June 13, 2001

pHyde, a new target gene in the treatment of prostate cancer

June 13, 2001

Adenoviral transfer of PTEN as a promising anticancer gene therapy

June 13, 2001

Enrollment in second rubitecan trial completed, triggering milestone payment

June 13, 2001

NIH awards Direct Therapeutics SBIR grant

June 13, 2001

U.S. patent covers cysteine protease inhibitors identified at Naeja

June 12, 2001

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 30, 2025.
Today's news in brief
Briefs
BioWorld MedTech briefs for Jan. 30, 2026.
Brain-derived tau in blood predicts stroke severity and outcome
BioWorld Science
Brain-derived tau, a protein that is exclusive to the brain and detectable in the blood, could serve as an indicator of brain damage after an ischemic stroke. The...
Centessa’s CNT-9982 shows promise for MDD
BioWorld Science
Orexin OX2 receptor agonists have demonstrated the ability to enhance wakefulness in rodent models, as well as in nonhuman primates and patients with narcolepsy...
First-in-class ADC targeting DEM-TXX shows high preclinical efficacy
BioWorld Science
Researchers at DEM Biopharma Inc. reported preclinical findings demonstrating the efficacy of DEM-301, a bifunctional antibody-drug conjugate (ADC) engineered to...